RNA-seq analysis of human pancreas cell line SU8686 treated with DOT1L inhibitor (SGC0946) or DMSO
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
To understand the pathway alteration associated with DOT1L inhibition, we performed RNA-seq analysis of DOT1L inhibitor treated human pancreas cell line SU8686. We reported the changed pathways. The SU8686 cells were treated with 20 μM SGC0946 or DMSO for 72 hr (triplicate)
创建时间：
2021-09-22
